Growth inhibition of human colorectal-carcinoma cells by interleukin-4 and expression of functional interleukin-4 receptors
- 1 November 1994
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 59 (3), 440-447
- https://doi.org/10.1002/ijc.2910590325
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation.The Journal of Experimental Medicine, 1993
- Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy.Journal of Clinical Oncology, 1992
- Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections – a phase I dose toxicity trialBritish Journal of Cancer, 1992
- Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells.JCI Insight, 1991
- Molecular cloning of a cDNA encoding the human interleukin 4 receptorInternational Immunology, 1990
- Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily.The Journal of Experimental Medicine, 1990
- Identification of interleukin 4 receptor‐associated proteins and expression of both high‐ and low‐affinity binding on human lymphoid cellsEuropean Journal of Immunology, 1989
- Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy?British Journal of Cancer, 1989
- B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines.The Journal of Experimental Medicine, 1986
- Identification of a T cell-derived b cell growth factor distinct from interleukin 2.The Journal of Experimental Medicine, 1982